⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13827817 | 1.00 | — | — | |
| SCHEMBL7278356 | 0.75 | — | — | |
| SCHEMBL757841 | 0.74 | — | — | |
| SCHEMBL3798816 | 0.74 | — | — | |
| SCHEMBL27541122 | 0.73 | ALDH1A1 (0.43) | — | |
| SCHEMBL289711 | 0.73 | — | — | |
| SCHEMBL104463 | 0.73 | — | — | |
| SCHEMBL27788890 | 0.72 | — | — | |
| SCHEMBL2266497 | 0.72 | SLC7A5 (0.48) | — | |
| Methylamine SCHEMBL29142806 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110402137-A | A kind of silica nodule delivery system, preparation method and use for targeted activation CD44 molecule | BEIJING INNO MEDICINE CO LTD | 2019-11-01 | — | — | CN | claimed |
| EP-2296479-B1 | VAPOUR OF A CITRUS ESSENTIAL OIL BLEND AND ITS ANTIMICROBIAL PROPERTIES | UNIV NORTHAMPTON (GB) | 2014-04-23 | — | — | EP | claimed |
| US-8133864-B2 | PAR-2 agonist | KOWA COMPANY, LTD. (JP) | 2012-03-13 | — | — | US | claimed |
| EP-1864994-B1 | PAR-2 AGONIST | KOWA CO (JP) | 2011-10-26 | — | — | EP | claimed |
| US-7910556-B2 | PAR-2 agonist | KOWA COMPANY, LTD. (JP) | 2011-03-22 | — | — | US | claimed |
| US-20090215703-A1 | PAR-2 Agonist | KOWA COMPANY, LTD. (JP) | 2009-08-27 | — | — | US | claimed |
| EP-1864994-A1 | PAR-2 AGONIST | Kowa Company, Ltd. (JP) | 2007-12-12 | — | — | EP | claimed |
| CN-110402137-A | A kind of silica nodule delivery system, preparation method and use for targeted activation CD44 molecule | BEIJING INNO MEDICINE CO LTD | 2019-11-01 | — | — | CN | disclosed |
| CN-109846871-A | Application of the aminooxoacetic acid in the drug of preparation treatment hepatocellular carcinoma | 重庆医科大学 | 2019-06-07 | — | — | CN | disclosed |
| US-20170173523-A1 | CO2 SORPTION BY SUPPORTED AMINO ACID IONIC LIQUIDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2017-06-22 | — | — | US | disclosed |
| CN-103112873-B | A kind of potassium fluosilicate prepares the method for high-purity potassium fluoride co-producing white carbon black | 金正大生态工程集团股份有限公司 | 2016-08-31 | — | — | CN | disclosed |
| CN-105454297-A | Bactericidal agent for controlling diseases of vegetables and fruit | XINJI YUAN XIANG GREEN ENERGY TECH CO LTD | 2016-04-06 | — | — | CN | disclosed |
| EP-2296479-B1 | VAPOUR OF A CITRUS ESSENTIAL OIL BLEND AND ITS ANTIMICROBIAL PROPERTIES | UNIV NORTHAMPTON (GB) | 2014-04-23 | — | — | EP | disclosed |
| EP-1799244-A1 | FURIN INHIBITORS | Smith, Judith (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20070128683-A1 | Metabolic delivery of coenzyme A analogs | NATIONAL SCIENCE FOUNDATION | 2007-06-07 | — | — | US | disclosed |
| WO-2007046781-A1 | FURIN INHIBITORS | SMITH, JUDITH (US) | 2007-04-26 | — | — | WO | disclosed |
| CN-1720258-A | Tumor targeting agents and uses thereof | KARYON OY (FI) | 2006-01-11 | — | — | CN | disclosed |
| CN-1720259-A | Tumor targeting agents and uses thereof | KARYON OY (FI) | 2006-01-11 | — | — | CN | disclosed |
| CN-1145834-C | Panel for liquid crystal display and manufacturing method thereof | �Ҵ���˾ | 2004-04-14 | — | — | CN | disclosed |
| CN-1330283-A | Panel for liquid crystal display and manufacturing method thereof | IBM (US) | 2002-01-09 | — | — | CN | disclosed |